title: Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis.
authors.affiliation: Toho University Medical Center Sakura Hospital, Chiba, Japan.
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Suzuki
authors.affiliation: IBD Center, Sapporo Kosei General Hospital, Sapporo, Japan.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Motoya
authors.affiliation: Hamamatsu South Hospital, Shizuoka, Japan.
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Hanai
authors.affiliation: IBD Centre, Kitasato University, Kitasato Institute Hospital, Tokyo, Japan. thibi@insti.kitasato-u.ac.jp.
authors.forename: Toshifumi
authors.initials: T
authors.lastname: Hibi
authors.affiliation: Hyogo College of Medicine Hospital, Nishinomiya, Hyogo, Japan.
authors.forename: Shiro
authors.initials: S
authors.lastname: Nakamura
authors.affiliation: AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Lazar
authors.affiliation: AbbVie, Inc., North Chicago, IL, USA.
authors.forename: Anne Martin
authors.initials: AM
authors.lastname: Robinson
authors.affiliation: AbbVie, Inc., North Chicago, IL, USA.
authors.forename: Martha
authors.initials: M
authors.lastname: Skup
authors.affiliation: AbbVie, Inc., North Chicago, IL, USA.
authors.forename: Nael Mohamed
authors.initials: NM
authors.lastname: Mostafa
authors.affiliation: AbbVie, Inc., North Chicago, IL, USA.
authors.forename: Bidan
authors.initials: B
authors.lastname: Huang
authors.affiliation: AbbVie, Inc., North Chicago, IL, USA.
authors.forename: Roopal
authors.initials: R
authors.lastname: Thakkar
authors.affiliation: Department of Gastroenterology, Tokyo Medical and Dental University, Tokyo, Japan.
authors.forename: Mamoru
authors.initials: M
authors.lastname: Watanabe